Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo, Mario Chojkier, Norman Gitlin, Massimo Puoti, Manuel Romero‐Gómez, Jean-Pierre Zarski, Kosh Agarwal, Peter Buggisch, Graham R. Foster, Norbert Bräu, Marı́a Buti, Ira M. Jacobson, G. Mani Subramanian, Xiao Ding, Hongmei Mo, Jenny C. Yang, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, Alessandra Mangia, Patrick Marcellin

New England Journal of Medicine, 2014

Hadassah Medical Center, Goethe University Frankfurt, University Medical Center, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, University of California San Diego Medical Center, Atlanta Gastroenterology Associates, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Hospital Universitario de Valme, Centre Hospitalier Universitaire de Grenoble, King's College - North Carolina, King's College Hospital, Asklepios Klinik St. Georg, Queen Mary University of London, James J. Peters VA Medical Center, Cornell University, Gilead Sciences (United States), Duke Medical Center, Casa Sollievo della Sofferenza, Hôpital Beaujon

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

1702

Citations

View on Google Scholar

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Abstract

Journal Details

Join JournalsHub

Welcome Back